focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
“The Company’s expectation is to generate operating losses and negative operating cash flows in the future and will need additional funding to support its current business plan. Management’s plans to alleviate the conditions that raise substantial doubt include the pursuit of additional cash resources through public or private equity or debt financings. There is no assurance that such funding will be available when needed or on acceptable terms. If additional funding is not available when required, the Company would need to delay or curtail its operations and its research and development activities until such funding is received, all of which could have a material adverse effect on the Company and its financial condition.”
Https://x.com/jarvy55/status/1790985152648077388?s=46&t=bAOa1BlMBm1NXAIfJMdsHQ
More SEC filings means not good news.
Good RNS from GCON ( Rural broadband solutions). One a minor investment though.
The website is updated, looks like we have also sold 10000 shares of cdt.
More sells. Aarghh!
They need too do something. All they keep doing is selling our investments too keep the lights on and pay their wages. Eventually we will run out of things to sell.
What then? Who is going too invest in a placing or fund raise. We would have no other option too sell CDT and it could be much lower by then.
On a positive note we are still invervalued on current assets. On a negative, JN and BF are still in charge and are as bad at investing as they are communicating with shareholders.
Maybe the market has had it right all along . Value vela at its live listed uk investments and discount CDT entirely , not the other way round which most on here had been assuming .
Ensilica doing well though !
Wouldn't be a bad shout lol, a trader will either lose our money quicker or make some profit for us, either way it's worth the risk at these levels
Selling CDT needs to be part of a wider strategic review and repurpose. One feels that more of the same would really be a pointless exercise.
Sell CDT and use a professional trader to make them some money.
VELA could have sold some at $5 and over but decided not to......
I agree, we need to sell CDT and get the funds into something else, ideally something that will produce a return!
Some good early buys today.
Re the CDT chat, their quarterly is not great at all, but you’ll see similar going concern wording in all the previous docs too. Nothing new. Only new ‘bad’ news is the apparent paucity of new news.
Looks like we’ll have company soon with SYME in the 1’s also now!
For once Joe I actually agree with you. Sell now and get the money in the bank. I have always hoped CDT would come too the rescue. Now I think they Should take the money and run.
Best thing Vela can do is just SELL UP.
On May 10, 2024, Adam Sragovicz informed the Board of Directors of his intention to resign as Chief Financial Officer of the Company.
A fraudster ?
Well done Vela 👏
Not a great tead
The Company’s expectation is to generate operating losses and negative operating cash flows in the future and will need additional funding to support its current business plan. Management’s plans to alleviate the conditions that raise substantial doubt include the pursuit of additional cash resources through public or private equity or debt financings. There is no assurance that such funding will be available when needed or on acceptable terms. If additional funding is not available when required, the Company would need to delay or curtail its operations and its research and development activities until such funding is received, all of which could have a material adverse effect on the Company and its financial condition.
CDT are FCKED. And so are Vela shareholders.
https://s3.amazonaws.com/sec.irpass.cc/2892/0001493152-24-019230.htm
Disappointed with the lack of activity and price movement today. There are increasingly some good signs, but the high dependency we now have on CDT ( which will be a godsend when CDT soars higher than $5 and beyond) is currently dragging us down as it circles three and then dips below. People are finding good investment odds elsewhere and the higher volumes on CDT suggest boredom sales aplenty. Scratching my head but remaining patient.
I’m afraid it’s not looking great with CDT. Just par returns for a while. Nothing much going on with clinical trials.
Not yet